Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

in Flushing. The structure is now almost completely enclosed in the reflective glass curtain wall. All that is left to complete are some sections at the ground floor close to the entrance to a ...

Excavation and pilings are nearing completion at the construction site of an upcoming 9-story commercial building at 37-18 138th St. in Flushing. As of the end of January 2025, most of the site ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

As you can see from the chart above the percentage of shares that are sold short for Elevance Health has grown since its last report. This does not mean that the stock is going to fall in the near ...

Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Felicia Norwood; Executive Vice ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

Americans predict that cutting out processed foods, healthy aging, and improving gut health will be the top three health trends in 2025, according to a recent study. The survey of 2,000 Americans ...